Abstract
A novel and efficient immunoaffinity column (IAC) based on bispecific monoclonal antibody (BsMAb) recognizing aflatoxin B1 (AFB1) and ochratoxin A (OTA) was prepared and applied in simultaneous extraction of AFB1 and OTA from food samples and detection of AFB1/OTA combined with ic-ELISA (indirect competitive ELISA). Two deficient cell lines, hypoxanthine guanine phosphoribosyl-transferase (HGPRT) deficient anti-AFB1 hybridoma cell line and thymidine kinase (TK) deficient anti-OTA hybridoma cell line, were fused to generate a hybrid-hybridoma producing BsMAb against AFB1 and OTA. The subtype of the BsMAb was IgG1 via mouse antibody isotyping kit test. The purity and molecular weight of BsMAb were confirmed by SDS-PAGE method. The cross-reaction rate with AFB2 was 37%, with AFG1 15%, with AFM1 48%, with AFM2 10%, and with OTB 36%. Negligible cross-reaction was observed with other tested compounds. The affinity constant (Ka) was determined by ELISA. The Ka (AFB1) and Ka (OTA) was 2.43 × 108 L/mol and 1.57 × 108 L/mol, respectively. Then the anti-AFB1/OTA BsMAb was coupled with CNBr-Sepharose, and an AFB1/OTA IAC was prepared. The coupling time and elution conditions of IAC were optimized. The coupling time was 1 h with 90% coupling rate, the eluent was methanol–water (60:40, v:v, pH 2.3) containing 1 mol/L NaCl, and the eluent volume was 4 mL. The column capacities of AFB1 and OTA were 165.0 ng and 171.3 ng, respectively. After seven times of repeated use, the preservation rates of column capacity for AFB1 and OTA were 69.3% and 68.0%, respectively. The ic-ELISA for AFB1 and OTA were applied combined with IAC. The IC50 (50% inhibiting concentration) of AFB1 was 0.027 ng/mL, the limit of detection (LOD) was 0.004 ng/mL (0.032 µg/kg), and the linear range was 0.006 ng/mL~0.119 ng/mL. The IC50 of OTA was 0.878 ng/mL, the LOD was 0.126 ng/mL (1.008 µg/kg), and the linear range was 0.259 ng/mL~6.178 ng/mL. Under optimum conditions, corn and wheat samples were pretreated with AFB1-OTA IAC. The recovery rates of AFB1 and OTA were 95.4%~105.0% with ic-ELISA, and the correlations between the detection results and LC-MS were above 0.9. The developed IAC combined with ic-ELISA is reliable and could be applied to the detection of AFB1 and OTA in grains.
Highlights
Mycotoxins are natural secondary metabolites produced by filamentous fungi under suitable conditions, among which aflatoxin B1 (AFB1) and ochratoxin A (OTA) are the most toxic and exist widely in grains [1,2,3,4]
In 2012, aflatoxins were listed in the group 1 classification by the International Agency for Research on Cancer (IARC), and OTA was classified as group 2B by IARC in
AFB1 and OTA in spiked corn and wheat samples were detected by immunoaffinity column (IAC) combined with enzyme-linked immunosorbent assay (ELISA), and confirmed by LC-MS
Summary
Mycotoxins are natural secondary metabolites produced by filamentous fungi under suitable conditions, among which aflatoxin B1 (AFB1) and ochratoxin A (OTA) are the most toxic and exist widely in grains [1,2,3,4]. An immunoaffinity column (IAC) could separate and concentrate mycotoxins in grain and effectively improve the matrix effect based on a specific and reversible interaction between antigen and antibody [32,33,34]. This may be one of the most applicable and adaptable procedures for mycotoxin detection [35]. In order to further investigate the preparation and properties of BsMAb, and explore its application prospects in IAC, a BsMAb against AFB1 and OTA was generated and characterized Based on this BsMAb, an IAC was prepared and applied in simultaneous extraction of AFB1 and OTA from food samples. The IAC was applied combined with ic-ELISA (indirect competitive ELISA) for AFB1 and OTA detection in food samples
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.